trial

A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men

NCTId NCT01060228
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 24 (actual)
Sponsored by Johnson & Johnson
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
24 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2009-01
Primary completion
—
Eligibility
MALE · 18 Years · 55 Years

Interventions & indications

Drugs
Paliperidonedivalproex sodium ER

Sponsors

Johnson & JohnsonLead Sponsor

Sites

0 total

Facts & assertions

3 sourced
Enrollment
24
Phase
PHASE1
Status
COMPLETED
relationships
The graph out of here
drug
Paliperidone
drug
divalproex sodium ER
drug
lead_sponsor
Johnson & Johnson
company
indication
Schizophrenia
indication
Epilepsy
indication
Schizophrenia
indication